General Proximity

A proximity discovery platform that identifies powerful proximity mechanisms for given targets, enabling development of highly-efficacious proximity therapeutics that control biology through protein interactions.

The team has been responsible for 40+ FDA approved medicines, 175+ INDs, 247 patents, and 983 publications. They have received major grants from ARPA-H and NCI, and earned a record number of big pharma "Golden Tickets" from companies including Servier, Astellas, Bristol Myers Squibb, AbbVie, and Ono Pharma.